Welcome to our dedicated page for BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund news (Ticker: xalcx), a resource for investors and traders seeking the latest updates and insights on BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund's position in the market.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
BNY Mellon Alcentra Global Multi-Strategy Credit Fund has completed its quarterly tender offer, which closed on November 12, 2020. The offer aimed to buy back up to 2.5% of its outstanding shares. The total tendered shares amounted to 205,585, with 66,325 shares set to be purchased. A pro-rata factor of 0.32261595 will be applied to the tendered shares. The purchase price is set at $94.81 per share, reflecting the fund's net asset value as of September 30, 2020. Investors seeking more details can contact Georgeson LLC or visit the SEC's website for further information.
BNY Mellon Alcentra Global Multi-Strategy Credit Fund has announced its initial quarterly tender offer for 2.5% of its outstanding shares. This Tender Offer will commence on October 14, 2020, and will expire on November 12, 2020, at 5:00 p.m. Eastern Time. The offer is based on the net asset value per share as of September 30, 2020. The Fund's Board has the discretion to conduct these quarterly offers until a liquidation plan is adopted. Shareholders will receive Offer Documents detailing the terms of the Tender Offer, which they should read carefully.